Assignee
ANGION BIOMEDICA CORP
US·20 granted patents·23 pending applications·66 citations·filing 2003–2021
Top patents by PatentIndex Score
43 records- 0189US9988374B2Cytochrome P450 inhibitors and uses thereofANGION BIOMEDICA CORP·Filed 2015·Granted Jun 5, 2018·4 cites·34 claims
- 0285US9597321B2Antifibrotic compounds and uses thereofANGION BIOMEDICA CORP·Filed 2015·Granted Mar 21, 2017·3 cites·21 claims
- 0384US10556893B2Cytochrome P450 inhibitors and uses thereofANGION BIOMEDICA CORP·Filed 2018·Granted Feb 11, 2020·3 cites·21 claims
- 0484US10414760B2Cytochrome P450 inhibitors and uses thereofANGION BIOMEDICA CORP·Filed 2016·Granted Sep 17, 2019·3 cites·4 claims
- 0583US7648978B2Small molecule modulators of cytokine activityANGION BIOMEDICA CORP·Filed 2005·Granted Jan 19, 2010·6 cites·32 claims
- 0682US10287282B2Methods and agents for treating diseaseANGION BIOMEDICA CORP·Filed 2015·Granted May 14, 2019·3 cites·11 claims
- 0782US9663471B2Pyrazole derivatives as modulators of hepatocyte growth factor (scatter factor) activityANGION BIOMEDICA CORP·Filed 2013·Granted May 30, 2017·4 cites·8 claims
- 0881US10851095B2Methods and agents for treating diseaseANGION BIOMEDICA CORP·Filed 2019·Granted Dec 1, 2020·2 cites·23 claims
- 0981US7879898B1Hepatocyte growth factor pathway activators in chronic obstructive pulmonary diseaseANGION BIOMEDICA CORP·Filed 2007·Granted Feb 1, 2011·7 cites·12 claims
- 1080US7192976B2Small molecule modulators of hepatocyte growth factor (scatter factor) activityANGION BIOMEDICA CORP·Filed 2003·Granted Mar 20, 2007·11 cites·5 claims
- 1179US10875849B2Solid forms of (E)-3-[2-(2-thienyl)vinyl]-1H-pyrazoleANGION BIOMEDICA CORP·Filed 2020·Granted Dec 29, 2020·1 cites·19 claims
- 1279US7265112B2Small molecule modulators of hepatocyte growth factor (scatter factor) activityANGION BIOMEDICA CORP·Filed 2004·Granted Sep 4, 2007·9 cites·3 claims
- 1379US7250437B2Small molecule modulators of hepatocyte growth factor (scatter factor) activityANGION BIOMEDICA CORP·Filed 2004·Granted Jul 31, 2007·9 cites·20 claims
- 1475US10195184B2Antifibrotic compounds and uses thereofANGION BIOMEDICA CORP·Filed 2017·Granted Feb 5, 2019·1 cites·25 claims
- 1569US11459319B2Cytochrome P450 inhibitors and uses thereofANGION BIOMEDICA CORP·Filed 2020·Granted Oct 4, 2022·0 cites·23 claims
- 1669US11434234B2Methods and agents for treating diseaseANGION BIOMEDICA CORP·Filed 2020·Granted Sep 6, 2022·0 cites·17 claims
- 1768US11504359B2Antifibrotic compounds and uses thereofANGION BIOMEDICA CORP·Filed 2019·Granted Nov 22, 2022·0 cites·26 claims
- 1866US10899750B2Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activityANGION BIOMEDICA CORP·Filed 2019·Granted Jan 26, 2021·0 cites·24 claims
- 1965US2019382348A1Pyrazole derivatives as modulators of hepatocyte growth factor (scatter factor) activityANGION BIOMEDICA CORP·Filed 2019·Application pending·0 cites
- 2061US2010137285A1Small molecule modulators of cytokine activityANGION BIOMEDICA CORP·Filed 2009·Application pending·0 cites
- 2160US2020071321A1Methods and uses of compounds for treating diseaseANGION BIOMEDICA CORP·Filed 2019·Application pending·0 cites
- 2260US2014256727A1Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activityANGION BIOMEDICA CORP·Filed 2014·Application pending·0 cites
- 2360US2019125731A1Antifibrotic compounds and uses thereofANGION BIOMEDICA CORP·Filed 2018·Application pending·0 cites
- 2459US11370783B2Solid forms of (E)-3-[2-(2-thienyl)vinyl]-1H-pyrazoleANGION BIOMEDICA CORP·Filed 2020·Granted Jun 28, 2022·0 cites·18 claims
- 2557US2023372299A1Preparation of terevalefim and formulations thereofANGION BIOMEDICA CORP·Filed 2021·Application pending·0 cites
- 2655US2018009793A1Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activityANGION BIOMEDICA CORP·Filed 2017·Application pending·0 cites
- 2755US2023312561A1Solid forms of (z)-methyl 3-(((4-(n-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxo-2,3-dihydro-1h-pyrrolo[2,3-b]pyridine-6-carboxylate and salts thereofANGION BIOMEDICA CORP·Filed 2021·Application pending·0 cites
- 2854US2023000828A1Improving renal function after kidney transplantationANGION BIOMEDICA CORP·Filed 2020·Application pending·0 cites
- 2952US2021171515A1Cytochrome p450 inhibitors and uses thereofANGION BIOMEDICA CORP·Filed 2021·Application pending·0 cites
- 3051US2008058312A1Modulators of hepatocyte growth factor/c-Met activityANGION BIOMEDICA CORP·Filed 2007·Application pending·0 cites
- 3151US2014171419A1Enhancement of cellular transplantation using small molecule modulators hepatocyte growth factor (scatter factor) activityANGION BIOMEDICA CORP·Filed 2014·Application pending·0 cites
- 3251US2014288136A1Methods and uses of cytochrome p450 inhibitorsANGION BIOMEDICA CORP·Filed 2014·Application pending·0 cites
- 3351US2007213319A1Modulators of hepatocyte growth factor/c-Met activityANGION BIOMEDICA CORP·Filed 2007·Application pending·0 cites
- 3450US2023295131A1Inhibitors of rho-associated coiled-coil kinaseANGION BIOMEDICA CORP·Filed 2021·Application pending·0 cites
- 3550US2016038490A1Compositions and methods for treating dysproliferative diseasesANGION BIOMEDICA CORP·Filed 2013·Application pending·0 cites
- 3650US2016152679A1Relaxin-like compounds and uses thereofANGION BIOMEDICA CORP·Filed 2013·Application pending·0 cites
- 3747US2022281841A1Ethynylheterocycles as rho-associated coiled-coil kinase (rock) inhibitorsANGION BIOMEDICA CORP·Filed 2020·Application pending·0 cites
- 3847US2014309234A1Small molecule anti-fibrotic compounds and uses thereofANGION BIOMEDICA CORP·Filed 2014·Application pending·0 cites
- 3945US2016060322A1Relaxin-like peptides and uses thereofANGION BIOMEDICA CORP·Filed 2013·Application pending·0 cites
- 4042US2014329871A1Small molecule anti-fibrotic compounds and uses thereofANGION BIOMEDICA CORP·Filed 2012·Application pending·0 cites
- 4142US2006025406A1Modulators of hepatocyte growth factor/c- Met activityANGION BIOMEDICA CORP·Filed 2005·Application pending·0 cites
- 4235US11542256B2Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitorsANGION BIOMEDICA CORP·Filed 2018·Granted Jan 3, 2023·0 cites·22 claims
- 4333US2022401423A1Methods for treating inflammatory bowel diseaseANGION BIOMEDICA CORP·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ANGION BIOMEDICA CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →